Periodic Reporting for period 2 - TITLY (Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma)

Non-Hodgkin lymphoma (NHL) is a form of cancer emerging from the transformation of a mature B- or T-cell lymphocyte. Clinically, NHL is usually characterized by lymph nodes and/or spleen enlargement, variable bone marrow or peripheral blood involvement and occasionally...